Tune into this episode which explores how engineered tRNAs could treat thousands of rare diseases and cancers that share the same mutation.
In this episode, titled ‘Scaling genetic medicine with tRNA‘, we will discuss the unique biology of tRNA and how it can be leveraged to scale the development of genetic medicines.
This conversation features Michelle Werner, CEO of Alltrna and CEO-Partner at Flagship Pioneering, and Caroline Köhrer, Vice President, Discovery Platform at Alltrna.
Key discussion points:
This podcast is in association with Molecular Devices. With its innovative life science technology, Molecular Devices makes scientific breakthroughs possible for academic, pharmaceutical, government and biotech customers. Head to moleculardevices.com to find out more.
Tune in to this episode to learn how overcoming the key challenges in personalised medicine could transform the future of healthcare.
Listen to this episode to discover how microbiomics is being leveraged to translate gut microbiome findings into new therapeutic options.
In this episode, we discuss the history of the AAPS Summer Scientific Forum, highlights from the 2024 event, and its goals for the future.
Unlock Exclusive Industry Insights
